Scynexis (SCYX) Revenue (2013 - 2026)
Scynexis' (SCYX) quarterly Revenue came in at $18.6 million in Q4 2025, up 1808.5% YoY from $977000.0 in Q4 2024, and up 5482.63% on a QoQ basis from $334000.0 in Q3 2025.
Scynexis (SCYX) Revenue (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 12 years of Revenue data on file, last reported at $18.6 million in Q4 2025.
- Quarterly Revenue rose 1808.5% year-over-year to $18.6 million in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $20.3 million (up 673.54% YoY) and the FY2025 annual result came in at $20.6 million, up 449.95% from the prior year.
- Revenue improved to $18.6 million in Q4 2025, from $334000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $131.5 million in Q2 2023 to a low of $257000.0 in Q1 2025.
- A 5-year average of $9.6 million and a median of $1.3 million in 2022 frame the typical range for Revenue.
- Annual changes were most pronounced in 2023 — Revenue jumped 9836.05% — and 2024, when it sank 99.44%.
- Tracing SCYX's Revenue over 5 years: stood at $597000.0 in 2021, then soared by 155.28% to $1.5 million in 2022, then soared by 280.38% to $5.8 million in 2023, then sank by 83.15% to $977000.0 in 2024, then jumped by 1808.5% to $18.6 million in 2025.
- The last three Revenue figures came in at $18.6 million (Q4 2025), $334000.0 (Q3 2025), and $1.4 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | 235,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 235,000.00 |
| Dec 31, 2025 | 18.65 Mn |
| Sep 30, 2025 | 334,000.00 |
| Jun 30, 2025 | 1.36 Mn |
| Mar 31, 2025 | 257,000.00 |
| Dec 31, 2024 | 977,000.00 |
| Sep 30, 2024 | 660,000.00 |
| Jun 30, 2024 | 736,000.00 |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | 5.80 Mn |
| Sep 30, 2023 | 1.76 Mn |
| Jun 30, 2023 | 131.45 Mn |
| Mar 31, 2023 | 1.13 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 1.56 Mn |
| Jun 30, 2022 | 1.32 Mn |
| Mar 31, 2022 | 700,000.00 |
| Dec 31, 2021 | 597,000.00 |
| Sep 30, 2021 | 516,000.00 |
| Mar 31, 2021 | 12.05 Mn |